IS5967A - Bóluefni til inntöku gegn niðurgangi - Google Patents

Bóluefni til inntöku gegn niðurgangi

Info

Publication number
IS5967A
IS5967A IS5967A IS5967A IS5967A IS 5967 A IS5967 A IS 5967A IS 5967 A IS5967 A IS 5967A IS 5967 A IS5967 A IS 5967A IS 5967 A IS5967 A IS 5967A
Authority
IS
Iceland
Prior art keywords
diarrhea
oral vaccine
vaccine
oral
Prior art date
Application number
IS5967A
Other languages
English (en)
Inventor
Carlin Nils
Askelöf Per
Bjare Ulf
Original Assignee
Sbl Vaccin Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbl Vaccin Ab filed Critical Sbl Vaccin Ab
Publication of IS5967A publication Critical patent/IS5967A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55544Bacterial toxins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IS5967A 1998-12-18 2001-06-13 Bóluefni til inntöku gegn niðurgangi IS5967A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9804415A SE515285C2 (sv) 1998-12-18 1998-12-18 Oralt vaccin mot diarré
PCT/SE1999/002306 WO2000037106A1 (en) 1998-12-18 1999-12-09 Oral vaccine against diarrhea

Publications (1)

Publication Number Publication Date
IS5967A true IS5967A (is) 2001-06-13

Family

ID=20413742

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5967A IS5967A (is) 1998-12-18 2001-06-13 Bóluefni til inntöku gegn niðurgangi

Country Status (25)

Country Link
EP (2) EP1444987A3 (is)
JP (1) JP2002532562A (is)
KR (1) KR20010101233A (is)
CN (1) CN1330552A (is)
AP (1) AP1426A (is)
AU (1) AU778223B2 (is)
BR (1) BR9916278A (is)
CA (1) CA2352309A1 (is)
CZ (1) CZ20011947A3 (is)
EE (1) EE200100309A (is)
HR (1) HRP20010433A2 (is)
HU (1) HUP0104552A3 (is)
ID (1) ID29857A (is)
IL (1) IL143808A0 (is)
IS (1) IS5967A (is)
MX (1) MXPA01006200A (is)
NO (1) NO20012889L (is)
NZ (1) NZ527559A (is)
OA (1) OA11729A (is)
PL (1) PL198438B1 (is)
SE (1) SE515285C2 (is)
TR (1) TR200101542T2 (is)
WO (1) WO2000037106A1 (is)
YU (1) YU41701A (is)
ZA (1) ZA200104362B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1372708B1 (en) * 2001-02-13 2008-06-18 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE ARMY Vaccine for transcutaneous immunization against travellers' diarrhoea
GB0121998D0 (en) 2001-09-11 2001-10-31 Acambis Res Ltd Attenuated bacteria useful in vaccines
EP1543836A1 (en) * 2003-12-17 2005-06-22 Berna Biotech AG Recombinant Vibrio cholerae strain and vaccine comprising said strain
WO2008133926A1 (en) * 2007-04-24 2008-11-06 Celldex Therapeutics, Inc: V. cholerae hyperexpressing recombinant cholera toxin b subunit showing dual immunogenicity
CA2846354C (en) * 2011-09-12 2023-04-25 Scandinavian Biopharma Holding Ab Vaccine for protection against etec-induced diarrhea comprising dmlt
KR101940357B1 (ko) * 2011-09-12 2019-01-18 스칸디나비안 바이오파마 홀딩 에이비 세포 표면 상 etec cs6 항원 제시의 증가 방법 및 그것의 수득가능한 산물들
RU2753410C2 (ru) * 2020-01-14 2021-08-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" Способ получения анатоксин-вакцины против эшерихиоза животных

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100556D0 (sv) * 1991-02-26 1991-02-26 Holmgren Jan Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans

Also Published As

Publication number Publication date
EP1140159A1 (en) 2001-10-10
AU778223B2 (en) 2004-11-25
EP1444987A2 (en) 2004-08-11
CN1330552A (zh) 2002-01-09
AU3088900A (en) 2000-07-12
MXPA01006200A (es) 2002-04-17
PL198438B1 (pl) 2008-06-30
NO20012889D0 (no) 2001-06-12
NO20012889L (no) 2001-06-12
PL348257A1 (en) 2002-05-20
YU41701A (sh) 2005-07-19
EE200100309A (et) 2002-08-15
WO2000037106A1 (en) 2000-06-29
ZA200104362B (en) 2002-01-14
IL143808A0 (en) 2002-04-21
SE9804415D0 (sv) 1998-12-18
JP2002532562A (ja) 2002-10-02
EP1444987A3 (en) 2005-12-21
ID29857A (id) 2001-10-18
AP1426A (en) 2005-06-06
OA11729A (en) 2005-05-12
TR200101542T2 (tr) 2001-10-22
CZ20011947A3 (cs) 2001-12-12
CA2352309A1 (en) 2000-06-29
SE515285C2 (sv) 2001-07-09
SE9804415L (sv) 2000-06-19
NZ527559A (en) 2005-01-28
BR9916278A (pt) 2001-09-04
KR20010101233A (ko) 2001-11-14
HRP20010433A2 (en) 2002-06-30
HUP0104552A3 (en) 2002-08-28
HUP0104552A2 (hu) 2002-04-29

Similar Documents

Publication Publication Date Title
NO20004758D0 (no) Vaksinesammensetning
ATE339223T1 (de) Kombinierte impfstoffzusammensetzungen
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
NO20003302L (no) Vaksine
EP1083926A4 (en) VACCINE
NO20004240L (no) Formuleringer
ID26720A (id) Komposisi oral
ID20233A (id) Komposisi oral
PT1069913E (pt) Composicoes oftalmicas gelificantes contendo goma xantana
IS5541A (is) Áfangatöflur til inntöku
ID19097A (id) Komposisi-komposisi oral
DE60007530D1 (de) Oral wirksame androgene
ID17860A (id) Komposisi vaksin
ID29128A (id) Gen untuk biosintesis epotilon
DE69922097D1 (de) Kessel
DK1023035T3 (da) Mundplejemiddel
DE69935609D1 (de) Formulierungen enthaltend cefuroxim-axetil
ID20466A (id) Komposisi oral
ID23772A (id) Komposisi-komposisi melalui mulut
NO20005599D0 (no) Vaksine
IS5967A (is) Bóluefni til inntöku gegn niðurgangi
ID23420A (id) Kemasan bungkus-susut
FI980053A0 (fi) Anordning foer utformande av fiberbollar av laongstraeckta fibrer som foeljer med enluftstroem